COM-IT-2 Immunotherapy combined with extensive radiotherapy for the treatment of stage IV non-small cell lung cancer
– a phase II randomised clinical and translational trial
- EudraCT number: 2021-003266
| Background/study objectives |
| Study design |
| Collaborative partners |
| Update/publications |